Gainers

  • Carver Bancorp, Inc.CARV shares climbed 201.37 percent to close at $11.00 on Thursday.
  • Eiger BioPharmaceuticals, Inc. EIGRshares rose 41.77 percent to close at $16.80.
  • OptimumBank Holdings, Inc. OPHCjumped 35.28 percent to close at $6.25 on Thursday.
  • Pluralsight, Inc. PSgained 33.33 percent to close at $20.00. Pluralsight priced its IPO at $15 per share.
  • NL Industries, Inc. NLsurged 26.67 percent to close at $9.50.
  • Seadrill LimitedSDRL shares rose 26.09 percent to close at $0.58.
  • Audentes Therapeutics, Inc. BOLDgained 21.91 percent to close at $41.39.
  • Evolus, Inc. EOLSshares climbed 20.93 percent to close at $12.94 on Thursday.
  • Loxo Oncology, Inc. LOXOgained 20.09 percent to close at $167.53. The biopharmaceutical company that focuses on medicines for patients with genetically defined cancers said its oral presentation of LOXO-292 was selected for the “Best of ASCO” program.
  • Essendant Inc. ESNDjumped 18.77 percent to close at $13.10. Essendant confirmed receipt of unsolicited proposal from Staples of $11.50 per share in cash.
  • Baozun Inc.BZUN shares rose 18.75 percent to close at $53.51 after reporting Q1 results.
  • Bright Scholar Education Holdings LimitedBEDU gained 17.71 percent to close at $18.54.
  • Ultra Petroleum Corp. UPLgained 17.65 percent to close at $2.40.
  • World Wrestling Entertainment, Inc. WWEshares surged 15.42 percent to close at $50.31. The company’s “Smackdown Live” may not be renewed at NBCUniversal network and the company’s “Monday Night Raw” program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter.
  • Black Box Corporation BBOXgained 14.29 percent to close at $2.60.
  • Drive Shack Inc. DSshares jumped 14.17 percent to close at $6.77 on Thursday.
  • Minerva Neurosciences IncNERV gained 13.85 percent to close at $7.40 after Journal of Clinical Psychiatry published positive results of cognitive performance from Phase 2B trial of roluperidone in schizophrenia patients.
  • CRISPR Therapeutics AGCRSP gained 13.44 percent to close at $65.40 on Thursday.
  • Halcón Resources CorporationHK climbed 13.18 percent to close at $5.58.
  • iPic Entertainment Inc. IPICshares rose 12.54 percent to close at $9.003 on Thursday.
  • Spectrum Pharmaceuticals, Inc. SPPIrose 12.11 percent to close at $20.00 after the company issued further details on Phase 3 ADVANCE study of ROLONTIS.
  • Blink Charging Co BLNKgained 11.4 percent to close at $8.01 on Thursday after surging 31.68 percent on Wednesday.
  • Williams Partners L.P. WPZshares rose 7.99 percent to close at $41.49 after The Williams Companies, Inc. WMB announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
  • Diana Containerships Inc. DCIXrose 7.74 percent to close at $1.67 after the company announced the sale of Post-Panamax Container Vessel for $21 million.
  • Endocyte, Inc. ECYTgained 7.56 percent to close at $13.51 after the company announced presentation of Phase 2 data from prostate cancer trial of 177Lu-PSMA-617 at the 2018 ASCO Annual Meeting.


Losers

  • Jounce Therapeutics, Inc.JNCE shares declined 35.2 percent to close at $11.45 on Thursday. Abstract of the Phase 1/2 ICONIC trial that evaluated JTX-2011 monotherapy as well as in combination with nivolumab showed that the company has met its target enrolment in its combination cohorts across four solid tumor types, namely gastric cancer, triple-negative breast cancer, head and neck squamous cell cancer and non-small cell lung cancer.
  • Syndax Pharmaceuticals, Inc. SNDXdipped 22.57 percent to close at $8.61 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.
  • Legacy Reserves LPLGCY shares fell 20.31 percent to close at $7.69.
  • Inspired Entertainment, Inc. INSEdropped 15.38 percent to close at $5.50.
  • China Internet Nationwide Financial Services Inc. CIFSdipped 13.88 percent to close at $24.82.
  • Dynavax Technologies CorporationDVAX declined 13.7 percent to close at $16.70. Dynavax announced that data will be presented from its ongoing Phase 1b/2 study investigating SD-101 in combination with KEYTRUDA® (pembrolizumab) at the 2018 ASCO Annual Meeting.
  • C. Penney Company, Inc.JCP fell 12.38 percent to close at $2.69 after the company reported downbeat Q1 results and lowered its FY2018 guidance.
  • Turtle Beach CorporationHEAR dipped 12.06 percent to close at $16.33.
  • Boxlight CorporationBOXL fell 11.99 percent to close at $8.66 on Thursday.
  • KEMET CorporationKEM dropped 11.95 percent to close at $18.65 following Q4 earnings.
  • HUYA Inc. HUYAshares fell 11.11 percent to close at $20.00 on Thursday.
  • Molecular Templates, Inc. MTEMshares dropped 10.71 percent to close at $7.34.
  • PetIQ, Inc. PETQshares fell 9.92 percent to close at $18.25
  • Teekay CorporationTK declined 9.89 percent to close at $8.11 following Q1 earnings.
  • Flowers Foods, Inc. FLOdropped 9.53 percent to close at $19.56 after reporting Q1 results.
  • Tuniu CorporationTOUR fell 8.95 percent to close at $6.82 on Thursday.
  • Jack in the Box Inc.JACK fell 8.3 percent to close at $83.79 after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
  • Aircastle Limited AYRfell 7.97 percent to close at $21.12 after announcing 7.9 million secondary offering of common shares.
  • Children’s Place, Inc.PLCE shares declined 7.95 percent to close at $127.025 after reporting downbeat results for its first quarter.
  • Nektar Therapeutics NKTRfell 7.66 percent to close at $79.23. Nektar Therapeutics announced that six abstracts accepted for presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
  • NetEase, Inc.NTES dropped 7.46 percent to close at $246.16 after reporting Q1 results.
  • Blueprint Medicines CorporationBPMC dropped 5.19 percent to close at $81.90 as the company reported 2 data presentations supporting plans for rapid development of Avapritinib.
  • Cisco Systems, Inc.CSCO fell 3.76 percent to close at $43.46. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.